Nifedipin Alternova (Nifedipine)

Nifedipine, the active ingredient in Nifedipin Alternova, is a calcium channel blocker presented as an oral formulation for oral use. It treats hypertension and angina pectoris in adult patients requiring blood pressure control or relief from chest pain.

GNH USA supplies Nifedipin Alternova as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand, with reliable logistics and comprehensive documentation, ensuring timely delivery to diverse healthcare settings.

Nifedipine is used to manage cardiovascular conditions that involve elevated blood pressure or myocardial oxygen demand.

Hypertension: lowers systemic blood pressure by reducing peripheral vascular resistance, helping prevent complications such as stroke and heart attack. Angina pectoris: alleviates chest pain by improving coronary blood flow and decreasing cardiac workload. Stable coronary artery disease: helps control symptoms and reduce the frequency of anginal episodes in patients with chronic ischemia.

Nifedipine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Flushing: warmth and redness, typically occurring shortly after dosing. - Peripheral edema: swelling of the ankles or lower legs. - Dizziness or light‑headedness, especially when standing quickly.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that can cause fainting. - Myocardial infarction: rare but possible in patients with pre‑existing coronary disease. - Life‑threatening arrhythmias: irregular heart rhythms requiring immediate medical attention.

When prescribing Nifedipine, clinicians should consider several safety measures to minimize risk.

Monitor blood pressure regularly: ensure therapeutic effect and detect hypotension. Avoid abrupt discontinuation: taper dose to prevent rebound hypertension. Use caution in hepatic impairment: reduced metabolism may increase plasma concentrations. Assess for heart failure: drug‑induced vasodilation can exacerbate fluid retention. Avoid concomitant grapefruit juice: may increase nifedipine exposure. Store at room temperature: keep in the original pack, protect from moisture.

Nifedipine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): can raise nifedipine levels. - Simvastatin high doses: increased risk of myopathy. - Diltiazem or verapamil: additive cardiovascular effects.

Moderate Interactions (Monitor Closely):\n- Beta‑blockers: may enhance bradycardia or hypotension. - Diuretics: combined effect on blood pressure may require dose adjustment. - NSAIDs: can blunt antihypertensive response.